Lv4
720 积分 2020-10-07 加入
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process
9天前
已完结
Unraveling the matrix stiffness landscape in idiopathic pulmonary fibrosis: GSN and ARG1 as novel diagnostic biomarkers and potential therapeutic targets
22天前
已完结
Targeting LIG1 to overcome oxaliplatin resistance by inducing PANoptosis in colorectal cancer
1个月前
已完结
A good practice guide to the administration of substances and removal of blood, including routes and volumes
1个月前
已完结
Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma
1个月前
已完结
The combination index (CI
2个月前
已完结
Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice
2个月前
已完结
Frequently asked questions in drug combinations and the mass-action law-based answers
2个月前
已完结
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
2个月前
已完结
Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands
2个月前
已完结
皖公网安备34019202002308
